We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$45.9B
AUM Growth
+$5.92B
Cap. Flow
-$190M
Cap. Flow %
-0.41%
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115

Sector Composition

Rank Sector Weight
1 Technology 20.79%
2 Healthcare 18.35%
3 Consumer Discretionary 12.96%
4 Financials 12.38%
5 Communication Services 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RICE
651
DELISTED
Rice Acquisition Corp.
RICE
$6.99M 0.02%
+645,000
New +$6.92M
HES
652
DELISTED
Hess
HES
$6.87M 0.02%
130,100
-136,700
-51% -$6.21M
TNGX icon
653
Tango Therapeutics
TNGX
$4.72B
$6.86M 0.02%
600,000
PWP icon
654
Perella Weinberg Partners
PWP
$1.26B
$6.81M 0.01%
+602,525
New +$6.28M
SBAC icon
655
SBA Communications
SBAC
$19.4B
$6.71M 0.01%
23,800
-100,900
-81% -$29.6M
HSIC icon
656
Henry Schein
HSIC
$9.83B
$6.7M 0.01%
100,200
-56,100
-36% -$3.62M
NGA.WS
657
DELISTED
Northern Genesis Acquisition Corp. Redeemable Warrants, each warrant exercisable for shares of commo
NGA.WS
$6.7M 0.01%
+1,187,500
New +$3.09M
OTIC
658
DELISTED
Otonomy, Inc.
OTIC
$6.63M 0.01%
1,025,500
IPGP icon
659
IPG Photonics
IPGP
$3.69B
$6.62M 0.01%
29,600
+10,300
+53% +$2.06M
RCUS icon
660
Arcus Biosciences
RCUS
$3.56B
$6.49M 0.01%
250,000
DCPH
661
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$6.45M 0.01%
113,000
-28,000
-20% -$1.66M
HYZN
662
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$6.36M 0.01%
+12,000
New +$6.27M
KDMN
663
DELISTED
Kadmon Holdings, Inc.
KDMN
$6.22M 0.01%
+1,500,000
New +$5.92M
ESI icon
664
Element Solutions
ESI
$9.37B
$6.21M 0.01%
+350,000
New +$4.84M
KYMR icon
665
Kymera Therapeutics
KYMR
$8.75B
$6.2M 0.01%
100,000
-150,000
-60% -$7.32M
FRT icon
666
Federal Realty Investment Trust
FRT
$10.2B
$6.16M 0.01%
72,400
-3,000
-4% -$250K
VNO icon
667
Vornado Realty Trust
VNO
$7.27B
$6.15M 0.01%
+164,759
New +$6.02M
STPK.WS
668
DELISTED
Star Peak Energy Transition Corp. Warrants, each whole warrant exercisable for one share of Class A
STPK.WS
$6.12M 0.01%
+1,033,333
New +$2.34M
ASH icon
669
Ashland
ASH
$3.32B
$6.06M 0.01%
76,503
+25,000
+49% +$1.89M
TKR icon
670
Timken Company
TKR
$8.92B
$6.03M 0.01%
77,943
-910,935
-92% -$62M
KRNY icon
671
Kearny Financial
KRNY
$604M
$6.01M 0.01%
568,945
-131,055
-19% -$1.24M
IRM icon
672
Iron Mountain
IRM
$36.3B
$6M 0.01%
203,452
-53,500
-21% -$1.48M
NUVB icon
673
Nuvation Bio
NUVB
$2.13B
$5.85M 0.01%
500,000
-300,000
-38% -$3.12M
WM icon
674
Waste Management
WM
$91.5B
$5.84M 0.01%
+49,514
New +$5.77M
SEE
675
DELISTED
Sealed Air
SEE
$5.74M 0.01%
125,375
+112,800
+897% +$4.89M

Similar funds

Adage Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
  • Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
  • Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
  • Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
  • Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
  • Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
  • Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.

Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.